CRP and metabolic dysfunction-associated steatotic liver disease: Levels of SFRP5 are lower in individuals with obesity, diabetes, non-alcoholic fatty liver disease, and hypertension and negatively correlated with C-reactive protein (CRP) (60, 137–142).